Intrinsic Value

AEMD doesn't have a meaningful market cap.

The intrinsic value of Aethlon Medical Inc (AEMD) under the Base Case is 0.58 USD per share. Compared with the current market price of 5.46 USD, the stock appears Overvalued by 89% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

AEMD Intrinsic Value
$0.58
Overvaluation 89%
Intrinsic Value
Price $5.46
Alert me when AEMD is below its intrinsic value
Today $0.47 · 91.4% below the current price

AEMD is cheaper than usual. Still overvalued, but less so than on 94% of days in the past 5 years.

Alternatives to AEMD

Fundamental Analysis

What Aethlon Medical Does

Health Care

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. The company is headquartered in San Diego, California and currently employs 9 full-time employees. The firm is focused on advancing the Hemopurifier (HP), a clinical-stage immunotherapeutic device intended for applications in cancer, life-threatening viral infections, and organ transplantation and other areas of significant unmet needs.

Headquarters
United States of America US
Employees
9
IPO date
Mar 9, 1994
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue AEMD Research

Decided on Aethlon Medical? Get an email when AEMD reaches the price you’d buy at. Free with an account.

Other Aethlon Medical listings

What is the Intrinsic Value of one AEMD stock?

The intrinsic value for Aethlon Medical Inc (AEMD) under the Base Case is 0.58 USD.

Is AEMD stock undervalued or overvalued?

Compared with the current market price of 5.46 USD, the stock appears Overvalued by 89% .

How reliable are our estimates? See how past valuations played out
Back to Top